Loading...
•
Dec 31, 2024
CareDx Q4 2024 Earnings Report
CareDx reported strong financial results for the fourth quarter and full year ended December 31, 2024, with significant revenue growth and a return to profitability.
Key Takeaways
CareDx announced a transformative year in 2024, achieving significant revenue growth and a return to profitability. The company reported a 32% year-over-year increase in Q4 revenue to $86.6 million and a 19% increase in full-year revenue to $333.8 million. Net income for Q4 was $87.7 million, a substantial improvement from a net loss in the prior year.
Fourth quarter revenue increased 32% year-over-year to $86.6 million.
Testing services revenue grew 37% year-over-year to $63.8 million, with volume increasing 14%.
GAAP net income for the fourth quarter was $87.7 million, a significant improvement from a net loss in the prior year.
Cash flow from operations for the fourth quarter was $21.9 million, contributing to a strong cash position of $261 million with no debt.
Revenue by Segment
Forward Guidance
For the full year 2025, CareDx expects revenue to be in the range of $365 million to $375 million and adjusted EBITDA to be in the range of $29 million to $33 million.
Positive Outlook
- Expected revenue growth for full year 2025.
- Anticipated positive adjusted EBITDA for full year 2025.
- Focus on testing services volume growth.
- Expansion of payer coverage.
- Commitment to operational excellence as the business scales.
Challenges Ahead
- No specific negative guidance was provided in the report.
- The guidance range for revenue and adjusted EBITDA is subject to various risks and uncertainties.
- General economic and market factors could impact performance.
- Global economic and marketplace uncertainties could affect results.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...